SynergenX Opens Testosterone Cypionate Therapy to Female Patients

Audio By Carbonatix

HOUSTON--(BUSINESS WIRE)--Aug 12, 2025--

SynergenX, national leader in customized hormone optimization, prescription weight loss, and medically supervised wellness, is expanding its hormone replacement therapy (HRT) services for women to include injections of testosterone cypionate. Beginning July 28, 2025, these services will be available at all locations nationwide.

This expansion marks the first time that female patients can access the custom-dosed testosterone cypionate injections available to male patients, enabling them to experience the benefits of injection-based testosterone therapy.

Testosterone Injections for Women

• An Expansion of Women’s HRT – Female patients at SynergenX have long been able to receive estrogen, progesterone, and testosterone therapies in the forms of pellets and creams. Now, female patients have access to the same custom-dosed testosterone care that their male counterparts do.
• Two paths for Testosterone Injections – Female patients will be able to choose from in-office injections or they may take part in the Self-Inject TRT program, allowing them to receive pre-filled syringes of testosterone delivered directly to their residences. Each path is guided by providers and informed by comprehensive lab analysis.
• Comprehensive Medical Onboarding – Female patients can begin treatment after an in-depth medical evaluation that includes an Autonomic Nervous System (ANS) test, metabolic panel, and a comprehensive hormone panel. Unlike male patients, women may begin therapy immediately upon presenting at least one qualifying symptom and receiving provider confirmation.

Raising the Standard in Women’s Hormone Health

Hormonal imbalances in women are often overlooked or treated with generic solutions. Developed in response to widespread clinical need, this program combines laboratory-grade diagnostics, expert clinical oversight, and flexible treatment delivery models, creating a new standard of care that prioritizes efficacy, safety, and long-term results.

“Testosterone cypionate injections are the gold standard of testosterone therapy, and I’m proud that our female patients can now have access to this life-changing treatment,” said Wayne Wilson, Founder and CEO of SynergenX. “At SynergenX we are committed to helping patients improve their lives through medically supervised hormone therapy, tailored to each individual according to need.”

About SynergenX

Headquartered in Houston, TX, SynergenX is an award-winning network of hormone health and wellness clinics serving Texas and Illinois. Lauded for its commitment to the highest clinical standards and custom-dosed hormone therapies, SynergenX is a front-runner in provider-led hormone therapy, weight loss, and wellness.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250812763893/en/

CONTACT: Media Contact:

Jordan Bailey

Marketing Communications Specialist, SynergenX / Low T Center

8326391569

jbailey@synergenxhealth.com

KEYWORD: UNITED STATES NORTH AMERICA TEXAS

INDUSTRY KEYWORD: WOMEN FITNESS & NUTRITION MEN OTHER HEALTH ALTERNATIVE MEDICINE HEALTH CONSUMER PHARMACEUTICAL GENERAL HEALTH

SOURCE: SynergenX

Copyright Business Wire 2025.

PUB: 08/12/2025 08:00 AM/DISC: 08/12/2025 08:00 AM

http://www.businesswire.com/news/home/20250812763893/en